IBDEI0P7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11245,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,11245,1,4,0)
 ;;=4^E11.3291
 ;;^UTILITY(U,$J,358.3,11245,2)
 ;;=^5138335
 ;;^UTILITY(U,$J,358.3,11246,0)
 ;;=E11.3292^^77^727^16
 ;;^UTILITY(U,$J,358.3,11246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11246,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,11246,1,4,0)
 ;;=4^E11.3292
 ;;^UTILITY(U,$J,358.3,11246,2)
 ;;=^5138336
 ;;^UTILITY(U,$J,358.3,11247,0)
 ;;=E11.3391^^77^727^17
 ;;^UTILITY(U,$J,358.3,11247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11247,1,3,0)
 ;;=3^DM Type 2 w/ Mod NPDR w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,11247,1,4,0)
 ;;=4^E11.3391
 ;;^UTILITY(U,$J,358.3,11247,2)
 ;;=^5138343
 ;;^UTILITY(U,$J,358.3,11248,0)
 ;;=E11.3392^^77^727^18
 ;;^UTILITY(U,$J,358.3,11248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11248,1,3,0)
 ;;=3^DM Type 2 w/ Mod NPDR w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,11248,1,4,0)
 ;;=4^E11.3392
 ;;^UTILITY(U,$J,358.3,11248,2)
 ;;=^5138344
 ;;^UTILITY(U,$J,358.3,11249,0)
 ;;=H35.3230^^77^727^24
 ;;^UTILITY(U,$J,358.3,11249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11249,1,3,0)
 ;;=3^Exudative ARMD,Bilateral
 ;;^UTILITY(U,$J,358.3,11249,1,4,0)
 ;;=4^H35.3230
 ;;^UTILITY(U,$J,358.3,11249,2)
 ;;=^5138528
 ;;^UTILITY(U,$J,358.3,11250,0)
 ;;=H35.3130^^77^727^37
 ;;^UTILITY(U,$J,358.3,11250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11250,1,3,0)
 ;;=3^Nonexudative ARMD,Bilateral
 ;;^UTILITY(U,$J,358.3,11250,1,4,0)
 ;;=4^H35.3130
 ;;^UTILITY(U,$J,358.3,11250,2)
 ;;=^5138510
 ;;^UTILITY(U,$J,358.3,11251,0)
 ;;=Z13.5^^77^727^52
 ;;^UTILITY(U,$J,358.3,11251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11251,1,3,0)
 ;;=3^Screening for Eye and Ear Disorders
 ;;^UTILITY(U,$J,358.3,11251,1,4,0)
 ;;=4^Z13.5
 ;;^UTILITY(U,$J,358.3,11251,2)
 ;;=^5062706
 ;;^UTILITY(U,$J,358.3,11252,0)
 ;;=Z48.02^^77^727^51
 ;;^UTILITY(U,$J,358.3,11252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11252,1,3,0)
 ;;=3^Removal of Sutures
 ;;^UTILITY(U,$J,358.3,11252,1,4,0)
 ;;=4^Z48.02
 ;;^UTILITY(U,$J,358.3,11252,2)
 ;;=^5063035
 ;;^UTILITY(U,$J,358.3,11253,0)
 ;;=Z48.810^^77^727^1
 ;;^UTILITY(U,$J,358.3,11253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11253,1,3,0)
 ;;=3^Aftercare Following EYE Surgery
 ;;^UTILITY(U,$J,358.3,11253,1,4,0)
 ;;=4^Z48.810
 ;;^UTILITY(U,$J,358.3,11253,2)
 ;;=^5063047
 ;;^UTILITY(U,$J,358.3,11254,0)
 ;;=H35.3131^^77^727^40
 ;;^UTILITY(U,$J,358.3,11254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11254,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degn,Early Dry Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,11254,1,4,0)
 ;;=4^H35.3131
 ;;^UTILITY(U,$J,358.3,11254,2)
 ;;=^5138511
 ;;^UTILITY(U,$J,358.3,11255,0)
 ;;=H35.3132^^77^727^41
 ;;^UTILITY(U,$J,358.3,11255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11255,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degn,Intermed Dry Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,11255,1,4,0)
 ;;=4^H35.3132
 ;;^UTILITY(U,$J,358.3,11255,2)
 ;;=^5138512
 ;;^UTILITY(U,$J,358.3,11256,0)
 ;;=H02.889^^77^727^35
 ;;^UTILITY(U,$J,358.3,11256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11256,1,3,0)
 ;;=3^Meibomian Gland Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,11256,1,4,0)
 ;;=4^H02.889
 ;;^UTILITY(U,$J,358.3,11256,2)
 ;;=^5157349
 ;;^UTILITY(U,$J,358.3,11257,0)
 ;;=Z96.1^^77^727^46
